124 females [64%]
Tirzepatide Reduces Liver Fat Better than Insulin In Diabetic Patients Compared to titrated insulin degludec, tirzepatide led to greater improvements in liver fat content and abdominal adipose tissue in adults with type 2 diabetes, according to an MRI sub-study of Eli Lilly and Company's phase 3 SURPASS-3 clinical trial
Gjermeni E, Kirstein AS, Kolbig F, Kirchhof M, Bundalian L, Katzmann JL, Laufs U, Blher M, Garten A, Le Duc D (2021) ObesityAn update on the Basic Pathophysiology and Review of recent therapeutic advances
We also explored several other known regulators of PGC1 activity that are altered in response to 5FU treatment in HCT116, including NRF2, reactive oxygen species and PPAR, but none of these prevented PGC1-driven increases in mitochondrial mass